European Commission grants approval of Ogsiveo
OGSIVEO is the first and only therapy to receive marketing authorization in the EU for the treatment of desmoid tumors
OGSIVEO is the first and only therapy to receive marketing authorization in the EU for the treatment of desmoid tumors
Rivaroxaban is used to treat venous thromboembolism
The company reported revenue from operations at Rs. 6,573.7 crore, up 6 per cent YoY
NorUDCA is the first?in?class treatment for Non?alcoholic Fatty Liver Disease (NAFLD) in India
Currently focused on platform-related queries, elva.AI is the first step in ekincare’s broader roadmap
The Q-Switched Nd:YAG system is suitable for all skin types and offers versatility in treating dermal and epidermal pigmentation
The partnership aims to co-develop technologies set to revolutionize manufacturing of plasmid DNA (pDNA), a critical raw material for advanced medicines
Cenexi reports an EBITDA breakeven for the quarter
The submission is supported by positive results from the Phase 3 AMPLIFY trial
Subscribe To Our Newsletter & Stay Updated